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ABSTRACT 
Objective:  To evaluate correlation of blood total cholesterol (TC), high-density lipoprotein (HDL), triglycerides, 
and the TC:HDL ratio as risk factors for ischemic stroke. 
Materials and Methods:  After ethical approval from hospital ethical board this case control study was 
conducted in the department of neurosurgery and neurology Lahore General Hospital Lahore/Punjab Institute of 
Neurosciences/ Postgraduate Medical Institute/Ameerudin Medical College Lahore. Duration of study was two 
years from October 2015 to October 2017. A total of 600 patients were included in the study after obtaining 
written consent from patients. After completion of data collection, data was entered in computer software SPSS 
version 23 and analyzed for continuous and categorical variables. Continuous/numerical variables were 
presented as mean and SD and categorical variables were presented in form of numbers and percentages. 
Independent t-test and chi-square test were applied to see significance of data. P value less than or equal to 0.05 
was considered as significant. 
Results:  Overall, 100% (n = 600) patients were included in this study. The study comprised of two equal groups, 
50% (n = 300) in each, i.e. cases and controls. The controls had mean total cholesterol (TC), High-density 
lipoprotein (HDL) and triglycerides 220.76 ± 4.29 mg/dL, 54.02 ± 4.45 mg/dL and 153.99 ± 2.68 mg/dL res-
pectively. The TC: HDL ratio was 5.48 ± 1.41 and 4.09 ± 1.22 for cases and controls respectively. The mean 
differences between total cholesterol (TC), High-density lipoprotein HDL, triglycerides and total cholesterol 
(TC): HCL ratios were statistically significant among both groups. 
Conclusion:  Results of our study revealed that significant difference was observed between cases and controls 
regarding the levels of Total cholesterol, HDL, triglycerides and TC:HDL ratio. Cases of ischemic stroke were 
found with high levels of TC, Tridlycerides, And TC:HDL ratio and low HDL , this difference was found 
statistically significant with P value 0.001. So it was concluded that hyperlipidemia has significant relation with 
ischemic stroke. 
Abbreviations:  TC: Total Cholesterol. HDL: High-density Lipoprotein. 
Keywords:  Ischemic Stroke, Total cholesterol, High density lipids, Triglycerides. 
 
INTRODUCTION 
Stroke is an enfeebling illness depicting hundreds of 
people to morbidity and mortality in the world/
1
 Inci-
dence of ischemic stroke is increasing day by day in 
Asian countries.
2
 Pakistan is the main country which is 
taking huge burden of desolating illness in terms of 
finance, resource expenditure, and health services and 
men power of this country.
3
 Exact incidence an epide-
miology of stroke is unknown in Pakistan, no extended 
literature is available. Considering the incidence of 
stroke in Pakistan some full text detailed studies nee-
ded which represents exact epidemiology, risk factors 
and needs of the time.
4
 Incidence of stroke in America 
is 700000 per annum and ranked as 3rd major cause of 
mortality. Its economic burden on managing the stroke 
and dealing with morbidities is about fifty billion dol-
lars.
5
 
 Among its risk factors increased total cholesterol
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and deficit of high density lipoprotein are established 
facts which can cause obstruction of coronary artery/ 
coronary heart disease. Many observational base stud-
ies have conducted showing role of lipid levels in risks 
of cerebral and vascular diseases. A recent meta-analy-
sis was conducted on this topic and shows that clinical 
trials on early lowering of lipids reported that no addi-
tional benefits were observed on risk of stroke. Out-
comes of statin intervention shows significant decrease 
in incidence of ischemic stroke. Statin acts by chang-
ing the cholesterol in blood serum through which 
ischemic stroke can be prevented according internat-
ional previous data. Recent conflict in international 
observations regarding serum lipid level and its rela-
tion with ischemic stroke and ischemic heart disease 
started new debate. 
 Correlation of lipid profile and ischemic stroke is 
not studied extensively in our population, and local 
lipid lowering guidelines are based on international 
data local data on this subject is deficient.  In this stu-
dy we investigated total cholesterol, high density lipid, 
triglycerides and TC:HDL ratio as risk factors of 
ischemic stroke, this data will help to establish local 
guidelines and base for future research on this subject. 
 
MATERIAL AND METHODS 
After ethical approval from hospital ethical board this 
case control study was conducted in thedepartment of 
neurology and neurosurgery Lahore General Hospital 
Lahore/Punjab Institute of Neurosciences/Postgraduate 
Medical Institute/Ameerudin Medical College Lahore. 
Duration of study was two years from October 2015 to 
October 2017. A total of 600 patients were included in 
the study after obtaining written consent from patients. 
Non probability consecutive sampling technique was 
used and sample size was calculated from WHO sam-
ple size calculator by using 95% CI, 80% power of 
study and proportion of  hyperlipidemia in case group 
21.7% and in 15.7% in control group. A focal neurolo-
gical deficit with sudden onset through vascular mech-
anism was labeled as stroke. Stroke was diagnosed 
clinically as well as through radiological investigations 
(computed tomography and magnetic resonance imag-
ing). We collected data of 600 patients of two catago-
ries (cases and controls). In case group 300 patients 
enrolled from indoor who were presented with neuro-
logical deficit. Complete detail history of these pati-
ents about smoking, diabetes, hypertension and alco-
hol use was taken. Blood sample of these patients was 
collected for hyperlipidemia and other baseline inves-
tigations. After complete laboratory investigation and 
diagnosis of stroke patient was included in this group. 
Patients in control group were enrolled from outdoor 
department of medicine who were presented with 
hypertension, diabetes and having history of smoking 
and alcohol use. Blood sample of these patients were 
taken for hyperlipidemia and other laboratory investi-
gations. 
 After completion of data collection, data was ente-
red in computer software SPSS version 24 and analy-
zed for continuous and categorical variables. Contin-
uous/numerical variables were presented as mean and 
SD like age, BMI, TC, HDL, Triglycerides and cate-
gorical variables were presented in form of numbers 
and percentages like gender, Diabetes, hypertension, 
alcohol use and exercise. Independent t-test and chi-
squar test was applied to see significance of data. P 
value less than or equal to 0.05 was considered as 
significant. 
 
RESULTS 
Overall, 100% (n = 600) patients were included in this 
study. The study comprised of two equal groups, 50% 
(n = 300) in each, i.e. cases and controls. The mean 
age and BMI of the cases was 57.33 ± 4.19 years and 
23.14 ± 2.38 kg/m
2
 respectively. While, the mean age 
and BMI of the controls was 57.04 ± 4.64 years and 
23.21 ± 2.06 kg/m
2
 respectively. The distribution of 
tobacco use, in cases, i.e. never, past, Current < 20/day 
and Current ≥ 20/day revealed as 38.3% (n = 115), 
45.7% (n = 137), 6% (n = 18) and 10% (n = 30) res-
pectively. While, in controls, the distribution of toba-
cco use i.e. never, past, Current < 20/day and Current 
≥ 20/day revealed as 36.3% (n = 109), 45.7% (n = 
137), 7.7% (n = 23) and 10.3% (n = 31) respectively. 
History of HTN noted as 54% (n = 162) and 25.3% 
(n = 76) for cases and controls respectively. There 
were 10.7% (n = 32) and 3% (n = 9) diabetes patients 
for cases and controls respectively. The distribution of 
alcohol use, in cases, i.e. daily, weekly, monthly and 
rare/never noted as 30.4% (n = 91), 40.3% (n = 121), 
14% (n = 42) and 15.3% (n = 46) respectively. While, 
in controls, the distribution of alcohol use, in cases, i.e. 
daily, weekly, monthly and rare/never noted as 26.7% 
(n = 80), 40.6% (n = 122), 15% (n = 45) and 17.7% 
(n = 53) respectively. There were, in cases, 43.7% (n = 
131) patients take exercise ≥ 2 times per week, 28.3% 
(n = 85) < 2 times per week and 28% (n = 84) patients 
do not take exercise. While, in controls, there were 
47.7% (n = 143) patients take exercise ≥ 2 times per 
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week, 29.7% (n = 89) < 2 times per week and 22.6% 
(n = 68) patients do not take exercise. History of 
hyperlipidemia observed as 26.3% (n = 79) and 16.3% 
(n = 49) for cases and controls respectively. The dif-
ferences between history of HTN, diabetes and history 
of hyperlipidemia were statistically significant, in gro-
ups (Table. 1). 
 The mean TC, HDL and triglycerides of the cases 
was 235.13 ± 4.25 mg/dL, 47.94 ± 5.60 mg/dL and 
194.20 ± 4.38 mg/dL respectively. While, for controls, 
the mean TC, HDL and triglycerides was 220.76 ± 
4.29 mg/dL, 54.02 ± 4.45 mg/dL and 153.99 ± 2.68 
mg/dL respectively. The TC: HCL ratio was 5.48 ± 
1.41 and 4.09 ± 1.22 for cases and controls respec-
tively. The mean differences between TC, HDL, tri-
glycerides and TC: HCL ratios were statistically signi-
ficant with regards to groups (Table 2). 
 
Table 1: 
 
Baseline Characteristics of the Study Groups 
Characteristics Cases (n = 300) Controls (n = 300) Test of Sig. 
Age (years) 57.33 ± 4.19 57.04 ± 4.64 t = 0.803, p = 0.422 
BMI* (kg/m2) 23.14 ± 2.38 23.21 ± 2.06 t = -0.384, p = 0.701 
Tobacco use 38.3% (n = 115) 36.3% (n = 109) χ2 = 0.787, p = 0.853 
Never    
Past 45.7% (n = 137) 45.7% (n = 137)  
Current <20/day 6% (n = 18) 7.7% (n = 23)  
Current ≥ 20/day 10% (n = 30) 10.3% (n = 31)  
History of HTN* 54% (n = 162) 25.3% (n = 76) χ2 = 51.5, p = 0.000 
Diabetes 10.7% (n = 32) 3% (n = 9) χ2 = 13.85, p = 0.000 
Alcohol use    
Daily 30.4% (n = 91) 26.7% (n = 80) χ2 = 1.31, p = 0.727 
Weekly 40.3% (n = 121) 40.6% (n = 122)  
Monthly 14% (n = 42) 15% (n = 45)  
Rare/never 15.3% (n = 46) 17.7% (n = 53)  
Exercise    
≥2 times per week 43.7% (n = 131) 47.7% (n = 143) χ2 = 2.31, p = 0.316 
< 2 times per week 28.3% (n = 85) 29.7% (n = 89)  
Rarely/never 28% (n = 84) 22.6% (n = 68)  
History of hyperlipidemia 26.3% (n = 79) 16.3% (n = 49) χ2 = 8.94, p = 0.003 
 
*BMI indicates body mass index; *HTN, hypertension. P < 0.05 is considered as significant. 
 
Table 2: 
 
Exposure Variables in Both Groups 
Characteristics Cases (n = 300) Controls (n = 300) Test of Sig. 
TC* mg/dL 235.13 ± 4.25 220.76 ± 4.29 t=41.17, p=0.000 
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HDL* mg/dL 47.94 ± 5.60 54.02 ± 4.45 t=-14.68, p=0.000 
Triglycerides mg/dL 194.20 ± 4.38 153.99 ± 2.68 t=135.58, p=0.000 
TC:HCL ratio 5.48 ± 1.41 4.09 ± 1.22 t=7.06, p=0.000 
 
*Total cholesterol; *High-density Lipoprotein; P < 0.05 is Considered as Significant. 
 
DISCUSSION 
Total increase in cholesterol or hyperlipidemia is fatal 
for healthy individuals; it may risk the person for 
minor diseases to serious ischemic strokes. People 
with history of hypertension, diabetes, smokers and 
alcohol users are more prone to this event 11. In our 
study we compared incidence of hyperlipidemia in 
cases (patients of ischemis stroke) with controls (pati-
ents with smoking, hypertension and diabetes) but not 
presented with ischemic stroke. Results of our study 
revealed that increase in HDL and triglyceride is not a 
risk factor for stroke but increase total cholesterol is 
alarming sign. 
 In a study Iso H et al
12
 reported that an increase in 
total serum cholesterol is associated with nonhemorr-
hagic stroke. This study is identical to our study. An-
other study conducted by Leppala JM et al
13
 in 1999 
reported that an association was found between 5% 
total cholesterol and ischemic stroke but only in smo-
kers, other habbits of alcohol and co morbid diseases 
hypertension and diabetes were not associated with it. 
Results of this study are also comparable with our 
results. 
 A study conducted by Koren-Morag N et al 14on 
patients of coronary artery disease and shows that 
increase in total cholesterol is associated with stroke 
and other cardiac and vascular diseases. A similar 
observational study was conducted by Shahar E et al
15
 
on non coronary artery patients and reported that there 
was no association was observed between stroke and 
serum lipids. Results of both studies are comparable 
with our results which show significance of our study 
and nullification of our results. 
 Another study conducted by Wannamethee SG 
et al
16
 in 2000 reported that HDL may be protective 
against stroke specially non fatal stroke. In another 
study Sacco RL et al
17
 reported that increase in HDL 
also protective against ischemic stroke in elderly pati-
ents. He reported that in patients of coronary heart 
disease high density lipids are inversely related to 
ischemic stroke means a low level of HDl ratio is a 
risk factor for CHD in adult patients. 
 In some trials which are conducted on reductase
inhibitors it was demonstrated that this phenomenon 
associated with reduced ischemic strokes and cardio-
vascular diseases. He demonstrated that lipid pheno-
menon is common in both events 18, 19, 20 32 – 36. 
Another study conducted by Kinosian B et al
21
 on 
cholesterol and coronary artery disease and demonstra-
ted that TC:HDL level is an important risk factor of 
coronary heart disease so its prevention is important in 
patients. Because of same mechanism of ischemic 
stroke was found in patients it is also a risk factor of 
ischemic stroke. Results of this study are also com-
parable with our findings. 
 
CONCLUSION 
Results of our study revealed significant difference 
between cases and controls regarding the levels of 
Total cholesterol, HDL, triglycerides and TC:HDL 
ratio. Cases of ischemic stroke were found with high 
levels of TC, Triglycerides, And TC:HDL ratio and 
low HDL, this difference was found statistically signi-
ficant with P value 0.001. So it was concluded that 
hyperlipidemia has significant relation with ischemic 
stroke. 
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